Mettler-Toledo International, Inc. $MTD Shares Purchased by Atlantic Union Bankshares Corp

Atlantic Union Bankshares Corp lifted its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 7.1% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,171 shares of the medical instruments supplier’s stock after acquiring an additional 143 shares during the quarter. Atlantic Union Bankshares Corp’s holdings in Mettler-Toledo International were worth $2,550,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in MTD. Greenleaf Trust lifted its stake in shares of Mettler-Toledo International by 1.2% in the first quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier’s stock worth $1,030,000 after buying an additional 10 shares in the last quarter. Brooklyn Investment Group grew its stake in shares of Mettler-Toledo International by 12.8% in the first quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier’s stock valued at $104,000 after buying an additional 10 shares in the last quarter. Sax Wealth Advisors LLC increased its stake in Mettler-Toledo International by 2.8% during the second quarter. Sax Wealth Advisors LLC now owns 372 shares of the medical instruments supplier’s stock worth $437,000 after purchasing an additional 10 shares during the period. TD Private Client Wealth LLC increased its stake in Mettler-Toledo International by 5.4% during the 1st quarter. TD Private Client Wealth LLC now owns 214 shares of the medical instruments supplier’s stock worth $253,000 after buying an additional 11 shares during the period. Finally, Horizon Investments LLC grew its stake in Mettler-Toledo International by 4.2% during the 1st quarter. Horizon Investments LLC now owns 299 shares of the medical instruments supplier’s stock worth $353,000 after purchasing an additional 12 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD opened at $1,438.69 on Friday. Mettler-Toledo International, Inc. has a one year low of $946.69 and a one year high of $1,454.68. The company’s fifty day moving average is $1,320.50 and its two-hundred day moving average is $1,235.22. The firm has a market capitalization of $29.64 billion, a P/E ratio of 36.43, a PEG ratio of 4.19 and a beta of 1.41.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, topping analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The firm had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $997.36 million. During the same quarter in the previous year, the firm earned $10.21 earnings per share. The firm’s revenue was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. On average, sell-side analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the completion of the transaction, the chief financial officer directly owned 5,095 shares in the company, valued at approximately $6,750,875. This trade represents a 5.56% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Thomas P. Salice sold 1,062 shares of the firm’s stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the transaction, the director directly owned 283 shares of the company’s stock, valued at $368,154.70. The trade was a 78.96% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 1,527 shares of company stock valued at $1,994,981. Insiders own 0.77% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on MTD shares. Robert W. Baird lifted their price objective on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research report on Monday, August 4th. Evercore ISI upped their target price on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a report on Tuesday, October 7th. Bank of America boosted their target price on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a report on Monday, September 22nd. Weiss Ratings reissued a “hold (c)” rating on shares of Mettler-Toledo International in a report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a research report on Thursday, October 9th. Five research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $1,336.50.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.